Syed Mehdi

Employment

• University of Arkansas Medical Center Instructor
  2019 - Present

Education

Education history is unavailable.

Projects & Funding

Projects & funding information is unavailable.

Publications (75)

• Development of New Diffuse Large B Cell Lymphoma Mouse Models
  Cancers 2024 DOI: 10.3390/cancers16173006
  +Save
• Bifunctional Inhibitor Reveals NEK2 as a Therapeutic Target and Regulator of Oncogenic Pathways in Lymphoma
  Mason McCrury, Kennith Swafford, Sydnye L. Shuttleworth +17 more
  Molecular Cancer Therapeutics 2024 DOI: 10.1158/1535-7163.MCT-23-0299
  +Save
• Data from Bifunctional Inhibitor Reveals NEK2 as a Therapeutic Target and Regulator of Oncogenic Pathways in Lymphoma
  2024 DOI: 10.1158/1535-7163.c.7104449.v1
  +Save
• Data from Bifunctional Inhibitor Reveals NEK2 as a Therapeutic Target and Regulator of Oncogenic Pathways in Lymphoma
  Mason McCrury, Kennith Swafford, Sydnye L. Shuttleworth +17 more
  2024 DOI: 10.1158/1535-7163.c.7104449
  +Save
• Figure S1 from Bifunctional Inhibitor Reveals NEK2 as a Therapeutic Target and Regulator of Oncogenic Pathways in Lymphoma
  Mason McCrury, Kennith Swafford, Sydnye L. Shuttleworth +17 more
  2024 DOI: 10.1158/1535-7163.25338008.v1
  +Save
• Figure S1 from Bifunctional Inhibitor Reveals NEK2 as a Therapeutic Target and Regulator of Oncogenic Pathways in Lymphoma
  Mason McCrury, Kennith Swafford, Sydnye L. Shuttleworth +17 more
  2024 DOI: 10.1158/1535-7163.25338008
  +Save
• Figure S10 from Bifunctional Inhibitor Reveals NEK2 as a Therapeutic Target and Regulator of Oncogenic Pathways in Lymphoma
  2024 DOI: 10.1158/1535-7163.25338005.v1
  +Save
• Figure S10 from Bifunctional Inhibitor Reveals NEK2 as a Therapeutic Target and Regulator of Oncogenic Pathways in Lymphoma
  Mason McCrury, Kennith Swafford, Sydnye L. Shuttleworth +17 more
  2024 DOI: 10.1158/1535-7163.25338005
  +Save
• Figure S11 from Bifunctional Inhibitor Reveals NEK2 as a Therapeutic Target and Regulator of Oncogenic Pathways in Lymphoma
  Mason McCrury, Kennith Swafford, Sydnye L. Shuttleworth +17 more
  2024 DOI: 10.1158/1535-7163.25338002.v1
  +Save
• Figure S11 from Bifunctional Inhibitor Reveals NEK2 as a Therapeutic Target and Regulator of Oncogenic Pathways in Lymphoma
  Mason McCrury, Kennith Swafford, Sydnye L. Shuttleworth +17 more
  2024 DOI: 10.1158/1535-7163.25338002
  +Save
• Figure S2 from Bifunctional Inhibitor Reveals NEK2 as a Therapeutic Target and Regulator of Oncogenic Pathways in Lymphoma
  Mason McCrury, Kennith Swafford, Sydnye L. Shuttleworth +17 more
  2024 DOI: 10.1158/1535-7163.25337999
  +Save
• Figure S2 from Bifunctional Inhibitor Reveals NEK2 as a Therapeutic Target and Regulator of Oncogenic Pathways in Lymphoma
  2024 DOI: 10.1158/1535-7163.25337999.v1
  +Save
• Figure S3 from Bifunctional Inhibitor Reveals NEK2 as a Therapeutic Target and Regulator of Oncogenic Pathways in Lymphoma
  Mason McCrury, Kennith Swafford, Sydnye L. Shuttleworth +17 more
  2024 DOI: 10.1158/1535-7163.25337996
  +Save
• Figure S3 from Bifunctional Inhibitor Reveals NEK2 as a Therapeutic Target and Regulator of Oncogenic Pathways in Lymphoma
  Mason McCrury, Kennith Swafford, Sydnye L. Shuttleworth +17 more
  2024 DOI: 10.1158/1535-7163.25337996.v1
  +Save
• Figure S4 from Bifunctional Inhibitor Reveals NEK2 as a Therapeutic Target and Regulator of Oncogenic Pathways in Lymphoma
  Mason McCrury, Kennith Swafford, Sydnye L. Shuttleworth +17 more
  2024 DOI: 10.1158/1535-7163.25337993.v1
  +Save
• Figure S4 from Bifunctional Inhibitor Reveals NEK2 as a Therapeutic Target and Regulator of Oncogenic Pathways in Lymphoma
  Mason McCrury, Kennith Swafford, Sydnye L. Shuttleworth +17 more
  2024 DOI: 10.1158/1535-7163.25337993
  +Save
• Figure S5 from Bifunctional Inhibitor Reveals NEK2 as a Therapeutic Target and Regulator of Oncogenic Pathways in Lymphoma
  Mason McCrury, Kennith Swafford, Sydnye L. Shuttleworth +17 more
  2024 DOI: 10.1158/1535-7163.25337990
  +Save
• Figure S5 from Bifunctional Inhibitor Reveals NEK2 as a Therapeutic Target and Regulator of Oncogenic Pathways in Lymphoma
  2024 DOI: 10.1158/1535-7163.25337990.v1
  +Save
• Figure S6 from Bifunctional Inhibitor Reveals NEK2 as a Therapeutic Target and Regulator of Oncogenic Pathways in Lymphoma
  Mason McCrury, Kennith Swafford, Sydnye L. Shuttleworth +17 more
  2024 DOI: 10.1158/1535-7163.25337987.v1
  +Save
• Figure S6 from Bifunctional Inhibitor Reveals NEK2 as a Therapeutic Target and Regulator of Oncogenic Pathways in Lymphoma
  Mason McCrury, Kennith Swafford, Sydnye L. Shuttleworth +17 more
  2024 DOI: 10.1158/1535-7163.25337987
  +Save